Author - simom

The regulator is considering approval of what would be the first CRISPR medicine, as well as...

Eledon’s investigational ALS drug tegoprubart could also help prevent organ transplant...

Leaders shaping the future of oncology and cancer care through grit and determination in the face...

Decisions that could spell doom for drugs in development and already on the shelves.

From COTA’s large datasets and AI model assistants to a company guiding patients through cancer...

The Flagship-backed biotech believes the secret to more precise drug delivery lies in the...

Leaders who’ve created unique strategies for thriving amid the heavy headwinds facing the...

Despite high rates of disease in older populations, systemic issues are keeping them out of...

Scientific discovery through new, breakthrough modalities is essential to solve current and future...

In today’s Biopharma landscape, considering Gross-to-Net is essential for effectively designing...